Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in Plaque Psoriasis
NCT04549870Phase 2Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roflumilast in plaque psoriasis, sponsored by Bispebjerg and Frederiksberg Hospital. Started Jan 2021; status: completed.
02
Drugs
roflumilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04549870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04549870.